| 000 | 01364 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513154055.0 | ||
| 264 | 0 | _c19990129 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0006-3223 | ||
| 024 | 7 |
_a10.1016/s0006-3223(97)00530-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerardi, D | |
| 245 | 0 | 0 |
_aClinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cOct 1998 |
||
| 300 |
_a748-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xepidemiology |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 700 | 1 | _aAmore, M | |
| 700 | 1 | _aKeck, P E | |
| 700 | 1 | _aTroia, M | |
| 700 | 1 | _aDell'Atti, M | |
| 773 | 0 |
_tBiological psychiatry _gvol. 44 _gno. 8 _gp. 748-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-3223(97)00530-1 _zAvailable from publisher's website |
| 999 |
_c9762502 _d9762502 |
||